🔴 Syncom Formulations is trading 5% down on October 26, 2026 with no clear company-specific cause identified

Syncom Formulations is trading 5.24% down at ₹20.08, with no clear company-specific announcement identified to explain the decline.

• The latest located filings concern routine compliance, including an October 8 certificate.
• The broader Indian market opened lower amid elevated crude prices and weak Asian markets, while pharma stocks were reported among the stronger sectors. That mixed backdrop does not clearly explain the stock’s sharper decline, so the cause remains uncertain.